Decreased ADAMTS13 activity in plasma from patients with thrombotic thrombocytopenic purpura

Thrombosis Research

Volumn 119, Issue 4, 2007, Pages 447-452

  Kobayashi, Toshihiko ^a   Wada, Hideo ^a   Kamikura, Yuko ^a   Matsumoto, Takeshi ^a   Mori, Yoshitaka ^b   Kaneko, Toshihiro ^a   Nobori, Tsutomu ^a   Matsumoto, Masanori ^c   Fujimura, Yoshihiro ^c   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Mie Red Cross Blood Center   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

ADAMTS13; FRET assay; TTP

Indexed keywords

VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VOLUNTEER;

ADAM PROTEINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPHOSPHOLIPID SYNDROME; CASE-CONTROL STUDIES; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 33846406399     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.04.007     Document Type: Article

References (26)

1. Bukowski R.M. Thrombotic thrombocytopenic purpura: a review. Rev Prog Hemost Thromb 6 (1982) 287-337
2. Amorosi E.L., and Ultman J.E. Thrombotic thrombocytopenic purpura: report of the 16 cases and review of the literature. Medicine 45 (1966) 139-159
3. Moake J.L., Rudy C.K., Troll J.H., Weinstein M.J., Colannino N.M., Azocar J., et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307 (1982) 1432-1435
4. Chow T.W., Turner N.A., Chintagumpala M., McPherson P.D., Nolasco L.H., Rice L., et al. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. Am J Hematol 57 (1998) 293-302
5. Ruggeri Z.M. Structure and function of von Willebrand factor. Thromb Haemost 82 (1999) 576-584
6. Furlan M., Robles R., and Lamie B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87 (1996) 4223-4234
7. Tsai H.-M. Physiologic cleavage of von Willebrand factor by a plasma protease is depend on its conformation and requires calcium ion. Blood 87 (1996) 4235-4244
8. Soejima K., Mimura N., Hirashima M., Maeda H., Hamamoto T., Nakagaki T., et al. A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease?. J Biochem 130 (2001) 475-480
9. Levy G.G., Nichols W.C., Lian E.C., Foroud T., McClintick J.N., McGee B.M., et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413 (2001) 488-494
10. Zheng X., Chung D., Takayama T.K., Majerus E.M., Sadler J.E., and Fujikawa K. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 276 (2001) 41059-41063
11. Fujikawa K., Suzuki H., McMullen B., and Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98 (2001) 1662-1666
12. Gerritsen H.E., Robles R., Lammle B., and Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 98 (2001) 1654-1661
13. Kokame K., Matsumoto M., Soejima K., Yagi H., Ishizashi H., Funato M., et al. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci U S A 99 (2002) 11902-11907
14. Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339 (1998) 1578-1584
15. Tsai H.M., and Lian E.C. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339 (1998) 1585-1594
16. Mori Y., Wada H., Gabazza E.C., Minami N., Nobori T., Shiku H., et al. Defective von Willebrand factor-cleaving activity on admission is a marker of excellent clinical response to plasma exchange in patients with thrombotic thrombocytopenic purpura. Transfusion 42 (2002) 572-580
17. Kokame K., Nobe Y., Kokubo Y., Okayama A., and Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 129 (2005) 93-100
18. Ghirardello A., Doria A., Ruffatti A., Rigoli A.M., Vesco P., Calligaro A., et al. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tool for the diagnosis of aPL syndrome?. Ann Rheum Dis 53 (1994) 140-142
19. Furlan M., Robles R., Solenthaler M., Wassmer M., Sandoz P., and Lammle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 89 (1997) 3097-3103
20. Matsumoto M., Yagi H., Ishizashi H., Wada H., and Fujimura Y. The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Semin Hematol 41 (2004) 68-74
21. Uchida T., Wada H., Mizutani M., Iwashita M., Ishihara H., Shibano T., et al. Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura. Blood 104 (2004) 2081-2083
22. Kokame K., Matsumoto M., Fujimura Y., and Miyata T. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood 103 (2004) 607-612
23. Mannucci P.M., Capoferri C., and Canciani M.T. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease. Br J Haematol 126 (2004) 213-218
24. Rougier N., Kazatchkine M.D., Rougier J.P., Fremeaux-Bacchi V., Blouin J., Deschenes G., et al. Human complement factor H deficiency associated with hemolytic uremic syndrome. J Am Soc Nephrol 9 (1998) 2318-2326
25. Noris M., Brioschi S., Caprioli J., Todeschini M., Bresin E., Porrati F., et al. International Registry of Recurrent and Familial HUS/TTP: Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 362 (2003) 1542-1547
26. Park Y.D., Yoshioka A., Kawa K., Ishizashi H., Yagi H., Yamamoto Y., et al. Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation. Bone Marrow Transplant 29 (2002) 789-794